Evidence map›Paper›PMID 28571307›Full record

ArticleAMB Express2017

Variants of lipopeptides and glycolipids produced by Bacillus amyloliquefaciens and Pseudomonas aeruginosa cultured in different carbon substrates.

Thando Ndlovu, Marina Rautenbach, Sehaam Khan, Wesaal Khan

Open access · goldAbstract read
In one paragraph

Article in AMB Express, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Bioformulation ofFrontiers in bioengineering and biotechnology · 2024
    Article
  3. Process Development in Biosurfactant Production.Advances in biochemical engineering/biotechnology · 2022
    Review
  4. Review
  5. Biosurfactant Production Using Mutant Strains ofAdvanced pharmaceutical bulletin · 2021
    Article
  6. Rhamnolipid exhibits anti-biofilm activity against the dermatophytic fungiBiotechnology reports (Amsterdam, Netherlands) · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Thando NdlovuDepartment of Microbiology, Faculty of Science, Stellenbosch University, Private Bag X1, Stellenbosch, 7602, South Africa.
Marina RautenbachBIOPEP Peptide Group, Department of Biochemistry, Faculty of Science, Stellenbosch University, Private Bag X1, Stellenbosch, 7602, South Africa.
Sehaam KhanFaculty of Health and Applied Sciences, Namibia University of Science and Technology, 13 Storch Street, Private Bag 13388, Windhoek, Namibia.
Wesaal KhanDepartment of Microbiology, Faculty of Science, Stellenbosch University, Private Bag X1, Stellenbosch, 7602, South Africa. wesaal@sun.ac.za.
Stellenbosch University · ZANamibia University of Science and Technology · NA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quantitative and qualitative effect of water immiscible and miscible carbon-rich substrates on the production of biosurfactants, surfactin and rhamnolipids, by Bacillus amyloliquefaciens ST34 and Pseudomonas aeruginosa ST5, respectively, was analysed. A small-scale high throughput 96 deep-well micro-culture method was utilised to cultivate the two strains in mineral salt medium (MSM) supplemented with the water miscible (glucose, glycerol, fructose and sucrose) and water immiscible carbon sources (diesel, kerosene and sunflower oil) under the same growth conditions. The biosurfactants produced by the two strains were isolated by acid precipitation followed by an organic solvent extraction. Ultra-performance liquid chromatography coupled to electrospray ionisation mass spectrometry was utilised to analyse yields and characterise the biosurfactant variants. For B. amyloliquefaciens ST34, maximum surfactin production was observed in the MSM supplemented with fructose (28 mg L

Indexed as

Bacillus amyloliquefaciens ST34Carbon sourcesPseudomonas aeruginosa ST5RhamnolipidSurfactinUPLC–MS

Identifiers

PMID28571307
PMCPMC5451376
OpenAlexW2616904916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.